UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): February
16, 2005
NovaMed,
Inc.__________
(Exact
Name of Registrant as Specified in Charter)
Delaware |
0-26625 |
36-4116193 |
(State
or Other Jurisdiction |
(Commission |
(IRS
Employer |
of
incorporation) |
File
Number) |
Identification
No.) |
980
North Michigan Avenue, Suite 1620, Chicago, Illinois |
60611 |
(Address
of Principal Executive Offices) |
(Zip
Code) |
Registrant’s
telephone number, including area code (312)
664-4100
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act
o Soliciting material pursuant to Rule 14a-12 under the
Exchange Act
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
Section
2 - Financial Information
Item
2.02 Results of Operations and Financial Condition.
On
February 16, 2005, NovaMed, Inc. issued a press release announcing its results
of operations for the period ended December 31, 2004. A copy of the press
release is attached to this Current Report on Form 8-K as Exhibit
99.1.
The
information in this Form 8-K and Exhibit 99.1 attached hereto shall not be
deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, nor shall it be deemed incorporated by reference in any filing under the
Securities Act of 1933, except as shall be expressly set forth by specific
reference in such filing.
Section
9 - Financial Statements and Exhibits
Item
9.01 Financial Statements and Exhibits
(c) Exhibits
| |
Exhibit Number |
Title |
| |
99.1 |
Press release of NovaMed, Inc. dated
February 16, 2005 |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
| |
NovaMed,
Inc. |
|
|
|
| Dated: February 16, 2005 |
By: |
/s/ Stephen J. Winjum |
| |
Stephen J. Winjum |
| |
President
and Chief Executive Officer |
EXHIBIT
INDEX
| |
Exhibit Number |
Title |
| |
99.1 |
Press release of NovaMed, Inc. dated
February 16, 2005 |